| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 07/14/2005 | WO2005064008A1 Method and compositions for identifying anti-hiv therapeutic compounds |
| 07/14/2005 | WO2005064007A2 Means for screening a gtpase activity of controllers |
| 07/14/2005 | WO2005063992A1 Novel serum type streptococcus mutans and utilization of the same |
| 07/14/2005 | WO2005063986A1 Immune response regulatory protein |
| 07/14/2005 | WO2005063985A1 Probe set and method for identifying hla allele |
| 07/14/2005 | WO2005063982A1 Method of detecting target substance |
| 07/14/2005 | WO2005063977A1 Method of amplifying nucleic acid and method of detecting mutated nucleic acid using the same |
| 07/14/2005 | WO2005063973A1 Methods and kits for predicting an infectious disease state |
| 07/14/2005 | WO2005063967A1 Induction of myocardial cell with the use of mammalian bone marrow cell or cord blood-origin cell and fat tissue |
| 07/14/2005 | WO2005063817A2 Methods for identifying functional antibodies |
| 07/14/2005 | WO2005063816A2 Monovalent antibody fragments useful as therapeutics |
| 07/14/2005 | WO2005063803A1 Polypeptides for the diagnosis and therapy of leishmaniasis |
| 07/14/2005 | WO2005063801A2 Method for decreasing the contact between hepta-repeat region s of the corona-virus spike proteins and use thereof |
| 07/14/2005 | WO2005063796A1 Inhibitors of amyloid precursor protein processing |
| 07/14/2005 | WO2005063787A2 Propargyl substituted nucleoside compounds and methods |
| 07/14/2005 | WO2005063294A1 Inhibitor for the formation of ϝ-secretase complex |
| 07/14/2005 | WO2005063286A1 Antibodies for oncogenic strains of hpv and methods of their use |
| 07/14/2005 | WO2005062979A2 Immunoassays, haptens, immunogens and antibodies for anti-hiv therapeutics |
| 07/14/2005 | WO2005062952A2 Compositions and methods for modulating sirtuin activity |
| 07/14/2005 | WO2005062947A2 Methods and compositions for identifying rna-binding proteins |
| 07/14/2005 | WO2005062940A2 Method and apparatus for in vivo collection and surveillance of circulating biological components |
| 07/14/2005 | WO2005062929A2 Use of fc receptor polymorphisms as diagnostics for treatment strategies for immune-response disorders |
| 07/14/2005 | WO2005062918A2 Methods of treating asthma |
| 07/14/2005 | WO2005062770A2 Method for conducting pharmacogenomics-based studies |
| 07/14/2005 | WO2005062760A2 Non-androgen dependent roles for androgen receptor and non-androgen related inhibitors of androgen receptor |
| 07/14/2005 | WO2005062709A2 Integrated viral complexes, methods of production thereof, vaccines containing same and methods of use thereof |
| 07/14/2005 | WO2005062706A2 Methods of predicting a benefit of antioxidant therapy for prevention of cardiovascular disease in hyperglycemic patients |
| 07/14/2005 | WO2005049636A3 Method of analyzing protein |
| 07/14/2005 | WO2005047534A3 Methods and compositions for the response prediction of malig-nant neoplasia to treatment |
| 07/14/2005 | WO2005047519A3 Lsamp and nore 1 down-regulation in clear cell renal cell carcinomas |
| 07/14/2005 | WO2005040422A3 Differentially expressed genes related to coronary artery disease |
| 07/14/2005 | WO2005037997A3 Competition assay for identifying modulators of quadruplex nucleic acids |
| 07/14/2005 | WO2005028677A3 Systems and methods for determining cell type composition of mixed cell populations using gene expression signatures |
| 07/14/2005 | WO2005028109A3 Microplates useful for conducting thermocycled nucleotide amplification |
| 07/14/2005 | WO2005023990A3 Trans-splicing mediated photodynamic therapy |
| 07/14/2005 | WO2005021787A3 Human obesity susceptibility gene and uses thereof |
| 07/14/2005 | WO2005021778A3 Method and materials for polyamine catalyzed bisulfite conversion of cytosine to uracil |
| 07/14/2005 | WO2005017187A3 Methods for screening and identifying compounds |
| 07/14/2005 | WO2005012899A3 Method for error detection and increased confidence of sample decoding |
| 07/14/2005 | WO2005012568A3 In vitro gene expression assay for determining fluoropyrimidine sensitivity in chemotherapy |
| 07/14/2005 | WO2005005661A3 Genes regulated in ovarian cancer as prognostic and therapeutic targets |
| 07/14/2005 | WO2005001063A3 Polynucleotides capable of target-dependent circularization and topological linkage |
| 07/14/2005 | WO2005000871A3 Peptides antagonistic to an anti-angiogenic antibody and uses therefor |
| 07/14/2005 | WO2004108960A3 Methods for predicting drug efficacy in patients afflicted with hypertension |
| 07/14/2005 | WO2004081234A3 Dna analyzing apparatus, dna sensor, and analyzing method |
| 07/14/2005 | WO2004077014A3 Methods and compositions for detection and analysis of polynucleotide-binding protein interactions using light harvesting multichromophores |
| 07/14/2005 | WO2004069983A3 Microreactor architecture and methods |
| 07/14/2005 | WO2004060270A8 Compositions and methods for the diagnosis and treatment of tumor |
| 07/14/2005 | WO2004020969A3 Production of nanoparticles having a defined number of ligands |
| 07/14/2005 | WO2004017923A3 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix |
| 07/14/2005 | WO2003068916A3 Methods and apparatus for whole cell panning |
| 07/14/2005 | WO2003029424A3 Novel proteins and nucleic acids encoding same |
| 07/14/2005 | WO2002083862A3 Methods and compositions for identifying disease genes using nonsense-mediated decay inhibition |
| 07/14/2005 | US20050155113 Expression vector comprising nucleotide sequences coding norwalk virus capsid protein for use in generating vaccine for prevention and treatment of gastrointestinal disorders |
| 07/14/2005 | US20050155096 Expression vector comprising nucleotide sequences granulocyte colony stimulating factor for use as tool in diagnosis, prevention and treatment of cell proliferative disorders |
| 07/14/2005 | US20050155092 Mutant muscle protein nucleotide sequences for use in generating animal models for diagnosis and treatment of cardiovascular disorders |
| 07/14/2005 | US20050155091 Protein kinase gamma (Prkag3 ) regulator sequences for use as tool in directing heterologous gene expression and proteins for treatment of diabetes, obesity, insulin resistance and dyslipidemia |
| 07/14/2005 | US20050155089 Transport protein for use in identifying modulators for prevention and treatment of inflammation, cardiovascular, neurological, reproductive and developmental disorders |
| 07/14/2005 | US20050155087 Method of screening compounds |
| 07/14/2005 | US20050154538 Crystal structure of the 30S ribosome and its use |
| 07/14/2005 | US20050153927 Gene expression inhibition; drug screening; peroxisome proliferator-activated receptor agonists such as fenofibrate |
| 07/14/2005 | US20050153925 Compositions and their uses directed to transferases |
| 07/14/2005 | US20050153924 Antisense modulation of interferon gamma receptor 2 |
| 07/14/2005 | US20050153921 Methods of using mammalian RNase H and compositions thereof |
| 07/14/2005 | US20050153919 Oligonucleotide compositions and methods for treating disease including inflammatory conditions |
| 07/14/2005 | US20050153917 Gene overexpression/underexpression; antibodies; drug screening; kits |
| 07/14/2005 | US20050153912 Antiviral oligonucleotides targeting viral families |
| 07/14/2005 | US20050153889 Modulation of pericyte proliferation |
| 07/14/2005 | US20050153878 Fgfr agonists |
| 07/14/2005 | US20050153440 Using embryonic germ cell as model for monittoring and evaluating genomic imprinting; tissue engineering; tissue targeted therapy; regenerative medicine; gene silencing |
| 07/14/2005 | US20050153430 Automatic continuous processing during nucleic acid amplification |
| 07/14/2005 | US20050153417 Halohydrin dehalogenases and related polynucleotides |
| 07/14/2005 | US20050153415 Lysin for use as tool in prevention of clostridial infection |
| 07/14/2005 | US20050153414 Regulator of G-protein signaling (RGS) polypeptide for use as tools in identifying modulators of cell signaling; antitumor agents; mimetics |
| 07/14/2005 | US20050153396 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/14/2005 | US20050153388 Marker for antidepressant therapy and methods related thereto |
| 07/14/2005 | US20050153386 Bioweapon-detecting fibrous-network products and methods for making same |
| 07/14/2005 | US20050153385 Method for quantitatively determining homocysteine and a reagent for quantitative determination of homocysteine |
| 07/14/2005 | US20050153384 Identifying inhibitors of intracellular protein fibrillization |
| 07/14/2005 | US20050153383 Using monomeric von willebrand factor fragment as diagnostic tool in detecting defective metalloprotease cleavage activity and diagnosis of thrombotic thrombocytopenic purpura |
| 07/14/2005 | US20050153381 Monoclonal antibody for use in diagnosing oxidative phosphorylation system (OXPHOS) disorders; immunodiagnostics; focused proteomic analysis of mitochondrial proteins |
| 07/14/2005 | US20050153380 Quantifying transgenic protein expression using protease digestion and mass spectrometry; isotope-coded affinity tags (ICATs) and measuring polypeptide concentration |
| 07/14/2005 | US20050153379 Implantable biosensor for isolation of tumor cells, blood and cellular products |
| 07/14/2005 | US20050153378 Anti-dioxins monoclonal antibody suitable for assaying dioxins in environment and hybridoma producing the same |
| 07/14/2005 | US20050153375 CEA/NCA-based differentiation cancer therapy |
| 07/14/2005 | US20050153374 Peptides and polypeptides derived from the submaxillary gland of the rat, corresponding polyclonal and monoclonal antibodies, corresponding hybridomas and uses of these products for diagnosis, for detection or therapeutic purposes |
| 07/14/2005 | US20050153373 Isolated from Bacillus substilis; multimeric polypeptide antigens; antibodies; solid phase synthesis; reverse transcription; kits; immunohistochemistry |
| 07/14/2005 | US20050153372 Using calmodulin-dependent protein kinase and/or calcineurin as tool in detecting modulators of nervous system and brain disorders; enzyme inhibitors |
| 07/14/2005 | US20050153370 Method of enhancing signal detection of cell-wall components of cells |
| 07/14/2005 | US20050153363 Polymer arrays |
| 07/14/2005 | US20050153362 Polymer arrays |
| 07/14/2005 | US20050153361 Therapeutic and diagnostic applications of protein disulphide isomerases |
| 07/14/2005 | US20050153355 Water-soluble rhodamine dye conjugates |
| 07/14/2005 | US20050153354 Detection and quantification of analytes in solution using polymers |
| 07/14/2005 | US20050153353 Real-time polymerase chain reaction-based genotyping assay for beta2-adrenergic receptor single nucleotide polymorphism |
| 07/14/2005 | US20050153352 Using oncogenic protein (MG20) as tool in identifying modulators for diagnosis prevention and treatment of cell proliferative disorders |
| 07/14/2005 | US20050153351 Methods and compositions for detecting cancers associated with methylation of hMLH1 promoter DNA |
| 07/14/2005 | US20050153348 Using membrane protein expression pattern as diagnostic and prognostic tool in detection of breast, colon and lung tissue cell proliferative disorders |
| 07/14/2005 | US20050153347 Such as cytosine methylation via fragmenting, ligating, hybridizing capture probe, extending probe then amplifying, digesting with restriction enzymes, extending restriction enzymes in presence of dideoxynucleotide triphosphate, then hybridizing to array |
| 07/14/2005 | US20050153344 Transferring molecules of interest from an electrophoretic polymer gel to matrix assisted laser desorption/ionization plate via drying and aerosol deposition; high throughput assay and detection of single nucleotide polymorphisms |